Promegapoietin is a drug given during chemotherapy to increase blood cell regeneration. It is a colony-stimulating factor that stimulates megakaryocyte production.[1][2]

It functions by stimulating ligands for interleukin 3 and c-Mpl.[3]


  1. Kratz-Albers K, Scheding S, Möhle R, Bühring H, Baum C, Mc Kearn J, Büchner T, Kanz L, Brugger W (2000). [Expression error: Missing operand for > "Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin"]. Exp Hematol 28 (3): 335–46. doi:10.1016/S0301-472X(99)00152-6. PMID 10720698. 
  2. Definition of promegapoietin - NCI Dictionary of Cancer Terms
  3. Doshi P, Giri J, Abegg A, Favara J, Huynh M, Kahn L, Minnerly J, Pegg L, Villani-Price D, Siegel N, Staten N, Thomas J, McKearn J, Smith W (2001). [Expression error: Missing operand for > "Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways"]. Exp Hematol 29 (10): 1177–84. doi:10.1016/S0301-472X(01)00694-4. PMID 11602319. 

External links


  • Currently 0.00/5

Rating: 0.0/5 (0 votes cast) login to rate

Add to Favorite Print This Page Publish on Twitter
Bookmark and Share
close about Number of comments per page:
Time format: relative absolute
You need JavaScript enabled for viewing comments